PATENT CLAIM ANALYSIS

Application Number: 16360811
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "235800"]

Abstract:
Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.

Claim (Index 7):
A process for the manufacture of the compound of formula (I) according to  claim 1 , wherein R 7  is hydrogen as reflected in formula (Ia), characterized in that a compound of formula (1-4) whereby R 1 , R 2 , R 3 , R 4 , R 6  and n have the meaning according to  claim 1 , is reacted with a compound of formula (C) whereby R 8  and m have the meaning according to  claim 1 , and X\u2032 represents F, Cl, Br, I, boronic acid or a boronic acid ester in the presence of a suitable base, and a suitable palladium catalyst, optionally in the presence of a suitable ligand, forming a compound of formula (Ia) which is optionally subsequently deprotected to form a compound of general formula (I) wherein R 7  is hydrogen and R 1 , R 2 , R 3 , R 4 , R 6 , R 8  and n and m have the meaning as defined in  claim 1 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14350160', '14365895', '14400315', '14900599', '15032957']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8253714220018299
- 35 USC 102 Novelty (BERT): 0.6109235277291047
- Combined Prediction Score: 0.8039266325745574
- Mean Citation Score: 480.713422
- Max Citation Score: 558.1653
- Similarity Product: 490.185620735532

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test